AI Portfolio Summary
In 2025 Q4, PFM Health Sciences, LP maintained a portfolio of 103 distinct positions. The most significant new addition to the portfolio was GLAUKOS CORP, which now represents 2.27% of the total fund value. They heavily accumulated shares in ASCENDIS PHARMA A/S, increasing their position by 22.3%. Conversely, PFM Health Sciences, LP completely exited their position in SPDR SERIES TRUST.
Total Positions
103
Quarter
2025 Q4
Top Holding
THC (7.9%)
Top 10 Concentration
41.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 103
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
THC
TENET HEALTHCAR...
|
Healthcare | 7.88% | 7.21% |
#1
1
Prev: #2
|
3.2 | -63,887 | -13.8% |
P
S
|
397,767 | $79,044,258 | 2008 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 7.32% | 13.21% |
#2
1
Prev: #1
|
3.1 | -156,850 | -69.7% |
P
S
|
68,289 | $73,388,823 | 2008 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 4.58% | 4.95% |
#3
1
Prev: #4
|
2.0 | -278,770 | -52.6% |
P
S
|
251,562 | $45,945,284 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEN
PENUMBRA INC
|
Healthcare | 4.50% | 3.80% |
#4
2
Prev: #6
|
1.9 | -49,914 | -25.6% |
P
S
|
145,171 | $45,135,116 | 2015 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 3.78% | 2.22% |
#5
5
Prev: #10
|
3.6 | 32,374 | 22.3% |
P
S
|
177,685 | $37,889,549 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.29% | 3.08% |
#6
1
Prev: #7
|
1.4 | -27,907 | -29.2% |
P
S
|
67,743 | $33,007,777 | 2008 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 2.98% | 1.58% |
#7
11
Prev: #18
|
3.3 | 151,064 | 26.3% |
P
S
|
725,424 | $29,851,198 | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.34% | 1.31% |
#8
16
Prev: #24
|
1.0 | -20,668 | -6.3% |
P
S
|
306,506 | $23,444,644 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 2.31% | 1.33% |
#9
13
Prev: #22
|
2.9 | 89,883 | 7.6% |
P
S
|
1,270,894 | $23,181,107 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.31% | 0.62% |
#10
34
Prev: #44
|
3.2 | 105,951 | 185.1% |
P
S
|
163,197 | $23,146,231 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 2.27% | — |
#11
Prev: #—
|
2.9 | 201,676 | no change |
NEW
|
201,676 | $22,771,237 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 2.19% | 0.09% |
#12
57
Prev: #69
|
3.2 | 35,601 | 1538.5% |
P
S
|
37,915 | $21,969,847 | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 2.10% | 2.28% |
#13
4
Prev: #9
|
0.9 | -134,489 | -35.3% |
P
S
|
246,835 | $21,042,684 | 2008 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 2.10% | 1.80% |
#14
3
Prev: #17
|
0.9 | -18,347 | -13.7% |
P
S
|
115,336 | $21,016,526 | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.09% | 0.62% |
#15
28
Prev: #43
|
2.9 | 25,873 | 10.8% |
P
S
|
265,517 | $20,975,843 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 2.05% | — |
#16
Prev: #—
|
2.8 | 213,796 | no change |
NEW
|
213,796 | $20,537,244 | 2008 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 1.99% | 1.31% |
#17
6
Prev: #23
|
0.9 | -514,479 | -23.3% |
P
S
|
1,694,051 | $19,922,040 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRK
MERCK & CO INC
|
Healthcare | 1.97% | 1.53% |
#18
1
Prev: #19
|
0.9 | -48,634 | -20.6% |
P
S
|
187,834 | $19,771,407 | 2010 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 1.84% | 0.27% |
#19
39
Prev: #58
|
3.0 | 1,109,662 | 311.9% |
P
S
|
1,465,480 | $18,465,048 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 1.78% | — |
#20
Prev: #—
|
2.7 | 50,852 | no change |
NEW
|
50,852 | $17,872,952 | 2009 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.66% | — |
#21
Prev: #—
|
2.7 | 50,539 | no change |
NEW
|
50,539 | $16,683,429 | 2008 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WAT
WATERS CORP
|
Healthcare | 1.64% | 0.71% |
#22
19
Prev: #41
|
2.8 | 12,457 | 40.5% |
P
S
|
43,208 | $16,411,695 | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNC
CALL
CENTENE CORP DE...
|
CALL Option | 1.53% | — |
#23
Prev: #—
|
2.6 | 372,300 | no change |
NEW
|
372,300 | $15,320,145 | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
ASCENDIS PHARMA...
|
—
|
Bond/Debt | 1.51% | 1.21% |
#24
3
Prev: #27
|
0.6 | -860,000 | -7.5% |
P
S
|
10,655,000 | $15,134,895 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
DXCM
DEXCOM INC
|
Healthcare | 1.50% | — |
#25
Prev: #—
|
2.6 | 227,357 | no change |
NEW
|
227,357 | $15,089,684 | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
CALL
SPDR SERIES TRU...
|
CALL Option | 0.00% | 5.53% |
Sold All 😨
(Was: #3) |
0.3 | -717,400 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MCK
MCKESSON CORP
|
Healthcare | 0.00% | 4.30% |
Sold All 😨
(Was: #5) |
0.3 | -72,313 | -100.0% |
CLOSED
|
— | $— | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HUM
CALL
HUMANA INC
|
CALL Option | 0.00% | 2.20% |
Sold All 😨
(Was: #11) |
0.3 | -110,000 | -100.0% |
CLOSED
|
— | $— | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COR
CENCORA INC
|
Healthcare | 0.00% | 1.93% |
Sold All 😨
(Was: #14) |
0.3 | -80,493 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 0.00% | 1.51% |
Sold All 😨
(Was: #20) |
0.3 | -60,776 | -100.0% |
CLOSED
|
— | $— | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTRA
NATERA INC
|
Healthcare | 0.00% | 1.43% |
Sold All 😨
(Was: #21) |
0.3 | -115,596 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPY
SPDR S&P 500 ET...
|
ETF | 0.00% | 1.09% |
Sold All 😨
(Was: #31) |
0.3 | -21,210 | -100.0% |
CLOSED
|
— | $— | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IWM
PUT
ISHARES TR
|
PUT Option | 0.00% | 1.05% |
Sold All 😨
(Was: #32) |
0.3 | -56,700 | -100.0% |
CLOSED
|
— | $— | 2017 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 0.95% |
Sold All 😨
(Was: #35) |
0.3 | -130,742 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
CALL
BOSTON SCIENTIF...
|
CALL Option | 0.00% | 0.92% |
Sold All 😨
(Was: #36) |
0.3 | -122,000 | -100.0% |
CLOSED
|
— | $— | 2009 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 0.91% |
Sold All 😨
(Was: #37) |
0.3 | -248,079 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.00% | 0.86% |
Sold All 😨
(Was: #38) |
0.3 | -19,890 | -100.0% |
CLOSED
|
— | $— | 2012 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRTC
IRHYTHM TECHNOL...
|
Healthcare | 0.00% | 0.86% |
Sold All 😨
(Was: #39) |
0.3 | -64,998 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRNA
VERONA PHARMA P...
|
Unknown | 0.00% | 0.66% |
Sold All 😨
(Was: #42) |
0.3 | -80,416 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #45) |
0.3 | -356,818 | -100.0% |
CLOSED
|
— | $— | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #46) |
0.3 | -360,460 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WST
WEST PHARMACEUT...
|
Healthcare | 0.00% | 0.37% |
Sold All 😨
(Was: #52) |
0.3 | -18,365 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AZN
ASTRAZENECA PLC
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #53) |
0.3 | -61,795 | -100.0% |
CLOSED
|
— | $— | 2008 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #61) |
0.3 | -156,463 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.00% | 0.22% |
Sold All 😨
(Was: #63) |
0.3 | -28,648 | -100.0% |
CLOSED
|
— | $— | 2009 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
PUT
LIQUIDIA CORPOR...
|
PUT Option | 0.00% | 0.13% |
Sold All 😨
(Was: #67) |
0.3 | -76,300 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HIMS
HIMS & HERS HEA...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #68) |
0.3 | -22,915 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HUM
HUMANA INC
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #70) |
0.3 | -3,648 | -100.0% |
CLOSED
|
— | $— | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #71) |
0.3 | -75,138 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HOWL
WEREWOLF THERAP...
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #72) |
0.3 | -401,110 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 103 holdings